Teladoc Health, Inc. (NYSE:TDOC) Holdings Raised by M&T Bank Corp

M&T Bank Corp grew its position in Teladoc Health, Inc. (NYSE:TDOCGet Rating) by 49.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,096 shares of the health services provider’s stock after acquiring an additional 3,362 shares during the quarter. M&T Bank Corp’s holdings in Teladoc Health were worth $335,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. McCarthy Asset Management Inc. bought a new position in Teladoc Health during the 1st quarter worth $25,000. DB Wealth Management Group LLC acquired a new position in Teladoc Health during the 1st quarter worth $25,000. Oliver Lagore Vanvalin Investment Group acquired a new position in Teladoc Health during the 1st quarter worth $27,000. GoalVest Advisory LLC acquired a new position in Teladoc Health during the 1st quarter worth $31,000. Finally, Bank Julius Baer & Co. Ltd Zurich boosted its position in Teladoc Health by 962.0% during the 2nd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,062 shares of the health services provider’s stock worth $35,000 after acquiring an additional 962 shares during the period. 92.46% of the stock is currently owned by institutional investors.

Insider Transactions at Teladoc Health

In other news, SVP Daniel Trencher sold 1,000 shares of the company’s stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total transaction of $37,500.00. Following the completion of the sale, the senior vice president now owns 26,408 shares in the company, valued at approximately $990,300. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, SVP Daniel Trencher sold 1,000 shares of the company’s stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total transaction of $37,500.00. Following the completion of the sale, the senior vice president now owns 26,408 shares in the company, valued at approximately $990,300. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Arnnon Geshuri sold 4,098 shares of the stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $34.27, for a total value of $140,438.46. Following the sale, the insider now owns 76,182 shares of the company’s stock, valued at approximately $2,610,757.14. The disclosure for this sale can be found here. In the last quarter, insiders sold 7,845 shares of company stock worth $253,814. 1.55% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

TDOC has been the subject of a number of analyst reports. Oppenheimer reduced their price target on Teladoc Health from $55.00 to $45.00 in a research report on Thursday, October 27th. Canaccord Genuity Group cut their price objective on Teladoc Health from $45.00 to $43.00 in a report on Friday, October 28th. StockNews.com assumed coverage on Teladoc Health in a report on Wednesday, October 12th. They issued a “sell” rating for the company. Cowen cut their price objective on Teladoc Health to $30.00 in a report on Thursday, October 27th. Finally, Stifel Nicolaus cut their price objective on Teladoc Health from $36.00 to $30.00 in a report on Thursday, July 28th. One analyst has rated the stock with a sell rating, twenty-four have given a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $54.93.

Teladoc Health Stock Performance

Shares of TDOC stock opened at $32.30 on Tuesday. The company has a debt-to-equity ratio of 0.25, a current ratio of 3.13 and a quick ratio of 2.99. Teladoc Health, Inc. has a fifty-two week low of $23.08 and a fifty-two week high of $137.96. The stock’s 50-day moving average is $27.88 and its two-hundred day moving average is $32.67. The firm has a market cap of $5.23 billion, a P/E ratio of -0.53 and a beta of 0.97.

Teladoc Health (NYSE:TDOCGet Rating) last issued its earnings results on Wednesday, October 26th. The health services provider reported ($0.45) earnings per share for the quarter, topping the consensus estimate of ($0.59) by $0.14. The company had revenue of $611.40 million for the quarter, compared to analyst estimates of $609.45 million. Teladoc Health had a negative return on equity of 2.47% and a negative net margin of 424.40%. Analysts predict that Teladoc Health, Inc. will post -1.43 earnings per share for the current fiscal year.

Teladoc Health Company Profile

(Get Rating)

Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure.

Featured Articles

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOCGet Rating).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.